The plasma concentrations of atropine following i.v. or i.m. administration to surgical patients were determined by radioimmunoassay. When atropine sulphate 1 mg was given i.v. there was a rapid initial removal of the drug from the circulation in the first 10 min; thereafter the plasma concentration decreased more slowly. Atropine i.m. was rapidly absorbed with peak concentrations occurring at 30 min following injection. The plasma atropine concentration then decreased slowly, probably because of uptake of atropine by muscarinic cholinergic receptors. The chronotropic effect of atropine appeared to correspond to the concentration in plasma following i.m. administration. We conclude that i.m. atropine, as a premedication, should be given not later than 30 min before induction of anaesthesia.
Atropine is widely used as a premedicant for the reduction of secretions, protection against vagal overactivity and prevention of vomiting after operation (Kessel, 1974; Mirakhur et al., 1978) . It is of interest to compare the therapeutic effect of the drug with its blood concentration. However, it has not been possible to determine the small concentrations of atropine found in plasma following typical doses, because of the lack of a sensitive method. Earlier investigations were performed with radio-labelled atropine. An obvious limitation of these studies was that the radioactivity rather than the parent compound was measured. Kaiser and McLain (1970) adminisstered 14 C-labelled atropine i.m. to adult volunteers and found that the concentration of carbon-14 in the blood reached maximum concentration after 15-30 min. Beerman, Hellstrom and Rosen (1971) reported that, after i.v. administration of 3 H-labelled atropine to humans, the plasma concentrations of radioactivity decreased rapidly. Oral administration on the other hand, resulted in mnYimnm radioactivity in plasma after 1 h. (Fasth, Sollenberg and Sdrbo, 1975; Wurzburger et al., 1977) . They have only been used for determinations of atropine in experimental animals.
In the present investigation we determined the plasma concentrations of atropine following a singledose i.v. or i.m. administration of the drug as premedication to surgical patients. An improved version of the radioimmunoassay developed by Fasth, Sollenberg and Sorbo (1975) was used.
METHODS

Patients, atropine administration and anaesthesia
The patients (ages 16-73 yr) underwent elective operations of comparable severity and duration (cholecystectomy, proximal vagotomy, mastectomy, internal fixation of tibial fracture, hemicolectomy). Single doses of atropine sulphate 1 mg were given as premedication to (a) six male patients i.v. immediately before induction of anaesthesia and (b) i.m. 30 min before the start of anaesthesia to two male and two female patients. The method of anaesthesia was the same for all patients: sodium thiopentone for induction followed by suxamethonium to permit intubation of the trachea. Fentanyl with 70% nitrous oxide in oxygen was given to maintain anaesthesia. When required, muscle relaxation was achieved with pancuronium.
Heparinized blood samples were taken immediately before atropine administration and then at intervals (figs 2, 3). Plasma was separated by centrifugation and stored frozen until analysed.
Production of antiserum
The preparation of the immunogen (containing 21 residues of atropine per molecule of bovine serum albumin) has been described previously (Fasth, Sollenberg and Sorbo, 1975) . Five male inbred chinchilla rabbits were immunized with immunogen 0.1 mg intradermally (Vaitukaitis et al., 1971 ). Blood samples were collected from the marginal ear vein 3 weeks after immunization and then at 1-week intervals. Serum was separated by centrifugation and assayed for anti-atropine antibodies (Fasth, Sollenberg and Sorbo, 1975) . All animals responded with antibody production, which reached an optimum at 4-5 weeks after immunization. The concentration decreased slowly in four of the animals but in one it remained constant for 3 months. The antiserum used for the radioimmunoassay was harvested from the animals 9 weeks after the immunization.
Radioimmunoassay
A 2-ml aliquot of human plasma was mixed with 1 ml of sodium carbonate buffer 0.5 mol litre" 1 (pH 10.8) in an acid-washed test tube and extracted with 10 ml of benzene-1.5% isoamyl alcohol. The benzene phase was separated by centrifugation and atropine re-extracted into 0.5 ml of hydrochloric acid 1 mol litre"
1 . The latter was evaporated to dryness under vacuum over-night. To the residue was added 0.2 ml of sodium phosphate buffer 0.12 mol litre" 1 , pH 7.5, horse control serum 0.2 ml (Seronorm, Nyegaard & Co., Oslo, Norway) and 3 H-atropine 10 (ilitre containing atropine 20 pmol of specific activity 439 Ci mol" 1 (The Radiochemical Centre, Amersham). After thorough mixing, 0.1 ml of anti-atropine antiserum, diluted 1 : 20 with saline, was added. The sample was incubated at 25 °C for 60 min and saturated ammonium sulphate 0.5 ml was added. The precipitate was centrifuged 30 min later, washed twice on the centrifuge with 50% saturated ammonium sulphate 1 ml and dissolved in distilled water 1.5 ml. This solution was transferred to a counting vial containing 15 ml of a Triton X-100-toluene based scintillation liquid (Patterson and Greene, 1965) and the sample was counted in a liquid scintillation counter. The amount of atropine present in the serum samples was obtained from a standard curve, prepared by adding known amounts of atropine to human control serum (Hyland Division, Travenol Laboratories, Lessines, Belgium). Linearization of the standard curve was obtained by plotting the quotient of the radioactivity bound in the absence (BQ) and in the presence (B) of unlabelled atropine v. the amount of the latter ( fig. 1 ). The precision of the assay was evaluated by 19 repeated determinations of B o jB for serum containing atropine l.Sngml" 1 . The result obtained was 1.24±0.055 (mean+ SD). The sensitivity of the method, defined as the amount of atropine giving a B o /B quotient significantly greater than 1.00, was 0.9 ng in the assay, corresponding to an atropine concentration in plasma of 0.5 ng ml" 1 .
RESULTS
Atropine in plasma
Following an injection of atropine i.v. there was a rapid reduction of plasma concentrations within the first 10 min ( fig. 2) . It was calculated that the amount of atropine remaining in the circulation at 10 min after injection corresponded to less than 5% of the dose administered. Plasma concentrations then decreased more slowly during the following 50 min. One hour after i.v. administration, the plasma concentration was approximately the same as after ijn. I.m. atropine was rapidly absorbed, reaching peak concentrations in plasma at 30 min ( fig. 3) . Plasma concentrations then decreased slowly, but were still detectable at 240 min after injection. The concentration after 1 h corresponded to that after i.v. administration.
Radioimmunoassay
The antiserum used was raised by intradermal immunization and was of a slightly greater potency than that obtained earlier after subcutaneous administration of the antigen (Fasth, Sollenberg and Sbrbo, 1975) . It thus bound 40% of the labelled atropine at a final dilution of 1 : 100, whereas the same effect was obtained with the earlier antiserum at 1:40 final dilution under otherwise identical conditions. Furthermore, the present antiserum recognized ( + )-hyoscyamine and ( -)-hyoscyamine (the two isomers of atropine) with equal efficiency, whereas the antiserum studied previously was less effective with (-)-hyoscyamine. We also verified that the drugs used for anaesthesia (sodium thiopentone, suxamethonium, fentanyl and pancuronium) were not recognized by the antiserum. In order to increase the sensitivity of the assay a concentration step, based on solvent extraction, was included. Various solvents were explored for this purpose and benzene, containing a small amount of isoamyl alcohol, gave the best results. The addition of isoamyl alcohol to non-polar solvents for extraction of basic drugs was originally suggested by Brodie, Udenfriend and Baer (1947) to prevent adsorption of the drug to glass surfaces. The yield of atropine in the concentration step was 84% but was corrected since both the standard and unknown plasma samples were taken through the same procedure.
DISCUSSION
A rapid initial removal of atropine from the circulation following injection i.v. was observed in the present investigation, confirming the findings of Beerman, Hellstrom and Rosen (1971) using 3 Hlabelled atropine. However, these authors reported that the initial decrease was followed by a transient increase at 45 min, which was not observed by us. Wurzburger and others (1977) , also using radioimmunoassay, observed a rapid decrease of blood concentrations of atropine in the dog after i.v. injection. This is probably a result of tissue uptake by muscarinic cholinergic receptors, as demonstrated in animals using radio-labelled atropine (Albanus et al., 1968) . Atropine is a mixture of two isomers, ( + )-and (-)-hyoscyamine, and only the latter is pharmacologically active. We found that less than 5% of the administered dose of atropine was present in the circulation 10 min after i.v. administration. As our radioimmunoassay detects both (+)-and (-)-hyoscyamine with equal efficiency, this indicates that the pharmacologically inactive ( + )-isomer also disappears from the circulation by tissue uptake. This interpretation is supported by a recent report (Aronstam, Abood and MacNeill, 1977) indicating that certain muscarinic cholinergic receptors bind anticholinergic drugs without stereo-selectivity. When atropine was administered by i.m. injection, the drug was rapidly absorbed with peak concentrations in plasma at 30 min. The plasma concentrations obtained at that time after i.m. injection were comparable to those found after i.v. administration. The clinical efficiency of the i.m. route for atropine is thus understandable. If the plasma concentration curve obtained after i.m. administration ( fig. 3) is compared with the time course of the cardiacaccelerating effect of the drug (Sidell, Magness and Bollen, 1970) , the heart rate closely follows the pattern set by the plasma concentrations. On the other hand, the depression of salivation is apparently a more delayed effect of atropine, reaching its peak effect about 100 min after i.m. administration (Murrin, 1973) . This illustrates the well known fact that plasma concentrations of a drug may not always run parallel to its pharmacological effects.
A recent survey carried out in Great Britain and Ireland (Mirakhur et al., 1978) showed that atropine was the most popular anticholinergic premedicant. The principal mode of administration is i.m. and the i.v. route is second. The results of the present investigation indicate that, when atropine is given as premedication by i.m. injection, this should be performed at least 30 min before the start of anaesthesia. a des opires. Lorsqu'on a administrf par voie intraveineuse du sulfete d'atropine a raison de 1 mg, on a constati a l'origine un retrait rapide du medicament de la circulation au cours des 10 premieres minutes; apres quoi les concentrations dans le plasma ont baissi plus lentement. L'atropine administxe> par voie intramusculaire a ttt rapidement absorbed, les concentrations de pointe se produisant 30 min apres Pinjection. Les concentrations d'atropine Harm le plasma ont ensuite baiss£ lentement, probablement a cause de la fixation de l'atropine par les recepteurs cholinergiques muscariniques. L'effet chronotropique de l'atropine semble correspondre a la concentration dans le plasma apres Padministration intramusculaire. Nous en concluons que l'atropine administrie par voie intraveineuse, en tant que prim^dicament, doit fine injected au moins 30 min avant l'induction de l'anesthesie. 
SUMARIO
Se determin6 por radioinmunoprueba las concentraciones de atropina en el plasma despu^s de la administracion i.v. 0 i.m. a pacientes sometidos a cirujla. Cuando se administro 1 mg de sulfato de atropina i.v., se produjo una remoci6n tnir-ifll ripida de la substancia en la circulation durante los primeros 10 min; despuis, la concentracidn en el plasma disminuyd mis despado. La atropina i.m. fue asimilada rapidamente con concentraciones mA-rimas 30 min despuis de la inyeccion. Luego, la concentraci6n de atropina en el plasma disminuyo despacio, probablemente por motive-de la captaci6n de la atropina por los receptores colinergicos muscarinicos. El efecto cronotropico de la atropina parecid corresponder a la concentracidn en el plasma despues de la administracidn ion. Llegamos a la conclusion de que la atropina i.m., como premedicacion, no debe administrarse sino a mis tardar 30 min antes de la inducci6n de la anestesia.
